Gilead Sciences Inc’s massive hepatitis C franchise is fading, the company warned on Tuesday, projecting that sales this year could be just two-thirds of what investors had been expecting.
Revenue from the company’s drugs for the viral infection would be US$7.5 billion to US$9 billion this year, Gilead said in a statement.
That is far below the US$11.6 billion analysts had projected, according to data compiled by Bloomberg. The company sells three main hepatitis C treatments — Sovaldi, Harvoni and Epclusa.
“This is a challenging situation,” Gilead Sciences chief executive officer John Milligan said during a conference call with analysts, adding that the hepatitis C market is “declining faster this year than we would have predicted last year.”
The shares fell after the new projection, and on Tuesday were down 5.4 percent to US$69.20 per share at 6:31pm in New York.
The hepatitis C pills — which have cut treatment times and side effects compared with older medicines — were the biggest drug launch of all time and are still massive products for the Foster City, California, company.
However, competitors Merck & Co and AbbVie Inc have cut into Gilead’s market share, forcing prices down and the bulk of the easiest-to-find patients might already have been treated, meaning that sales are expected to continue to decline.
The average US price of a one-month supply of Harvoni after discounts and rebates was less than US$15,000 last year, Milligan said.
For patients taking three months of treatment, that would be more than 52 percent off the list price of US$94,500.
Competition and shorter treatment duration for patients would reduce sales this year by US$1.9 billion to US$2.5 billion from last year’s figure, while fewer new patients starting on the drugs would mean US$2.9 billion to US$3.8 billion less in this year’s sales, Gilead said in a presentation released along with the projections.
While investors fret over what would replace the hepatitis C drugs, Gilead has said it wants to use acquisitions to fill its product pipeline.
However, it announced no new major deals and instead increased its dividend by more than 10 percent.
Milligan acknowledged that it would be “challenging to grow without some sort of acquisition” outside of the HIV franchise, and the firm’s chief financial officer Robin Washington said the company would focus on pursuing external opportunities in the coming year.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last